How Much Value Is Up For Grabs With Unilever plc, Reckitt Benckiser Group Plc & United Utilities Group plc?

This Fool recommends Unilever plc (LON:ULVR) and Reckitt Benckiser Group Plc (LON:RB) over United Utilities Group plc (LON:UU).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

United Utilities (LSE: UU) could be on the verge of receiving a takeover offer, according to market rumours. There might be other reasons to invest in its shares, however, although there are some obvious risks with UU. 

If you are after a near risk-free trade, you should rather buy either Unilever (LSE: ULVR) or Reckitt (LSE: RB), in my view. Here’s why…

A pricey bet

Goldman Sachs, Societe Generale and Bernstein have all raised their UU price targets in recent days. If they are right, pre-tax gains of at least 10% could be on the cards from its current level of 866p, which is closer to its 52-week low of 748p than to its 52-week high of 1,045p. The shares are down 6% in 2015.

I suspect that most utilities have become a less enticing yield play based on their net leverage and the projected level of growth for their cash flows and dividends. If this holds true, then United Utilities is likely to underperform other rivals, also in the light of its 20x forward earnings multiples.

It’s not cheap, and if you are willing to pay that much for any stock, you should snap up Unilever instead.

A compelling buy 

Unilever has surprised investors twice this year, reporting encouraging quarterly growth figures and a decent level of profitability. The problem with Unilever, if any, is that investors have doubts about the prospects for emerging markets, where its strength lay between early 2009 and mid-2013, during which period ULVR rose 30% a year on average.

Analysts at HSBC trimmed their price target to 3,050p on Thursday, and I have to agree that higher capital appreciation to the end of the year might be difficult to achieve from its current level of 2,570p. Like most stocks, ULVR has fallen a lot (-11%) since 6 August, but fundamentals remain solid.

It’s flat for the year, having outperformed the FTSE 100 by about four percentage points. 

This is a great buy if you are after long-term value. 

Buy or sell? 

Based on its earnings multiples, Reckitt is 20% more expensive than United Utilities and Unilever, and its valuation is even more demanding than that of the other two based on its core cash flows multiples. Is RB an obvious sell, then?

This is not an easy call, really, and even brokers have different views. JP Morgan rose its price target to 6,300p last week; HSBC decided to cut its price target to 5,900p on Thursday; similarly, Credit Suisse joined those in the bear camp at the end of August (6,100p). 

Well, its shares now trade at 5,744p, yet based on fundamentals, which are strong, Reckitt is the same company whose equity valuation stood at its all-time record of 6,300p only a month ago. Its rich valuation notwithstanding, its stock has proved to be more defensive than ULVR since 6 August, but UU has been more resilient in recent weeks. 

Alessandro Pasetti has no position in any shares mentioned. The Motley Fool UK owns and has recommended Unilever. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

Why does the FTSE 100 keep outperforming the S&P 500?

The FTSE 100 has outperformed the S&P 500 in 2025 and in the early days of 2026. What's happening here?…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

£1,000 buys 11,500 shares in this red hot healthcare penny stock that’s smashing GSK

This healthcare stock has delivered around twice the return of GSK shares in 2026. Believe it or not though, it…

Read more »

Businessman hand stacking up arrow on wooden block cubes
Investing Articles

This little known UK growth share is up 387% in five years. Time to buy?

Christopher Ruane looks at some pros and cons of a UK growth share that has been increasing its revenues significantly.…

Read more »

National Grid engineers at a substation
Investing Articles

Here’s how long it might take 100 National Grid shares to pay for themselves with dividends

With a dividend policy that aims to keep pace with inflation, National Grid shares appeal to some income investors. What…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

Under £5 now, are Barclays shares a screaming bargain following excellent 2025 results?

Barclays shares still look way too low to me, given rising earnings and big capital returns ahead — raising the…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

Just a £5,000 holding in BP shares could generate £1,807 in annual income for investors over time!

BP shares are throwing off far more dividend income than most investors realise -- and the latest numbers hint the…

Read more »

Middle aged businesswoman using laptop while working from home
Investing Articles

I’m itching to buy Barclays for my Stocks and Shares ISA. But am I too late?

Harvey Jones is looking to generate some income and growth from this year Stocks and Shares ISA allowance. But is…

Read more »

Two white male workmen working on site at an oil rig
Investing Articles

Why ‘HALO’ shares could be the FTSE 100’s biggest winners in 2026

The investment environment is changing rapidly due to AI disruption concerns. Amid this backdrop, there are certain FTSE 100 shares…

Read more »